Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 4, 2009
| Drug Name | Review Type | Class | Manufacturer |
|---|---|---|---|
| Sancuso | New Drug Initial Review | Antiemetic | ProStrakan |
| Moxatag | New Drug Initial Review | Antibiotic | MiddleBrook |
| Astepro | New Drug Initial Review | Nasal Preprarations | Meda |
| Trilipix | New Drug Initial Review | Lipotropics � Other | Abbott |
| Stavzor | New Drug Initial Review | Anticonvulsant | Noven |
| Janumet | New Drug Initial Review | Diabetes | Merck |
| Banzel | New Drug Initial Review | Anticonvulsant | Eisai |
| Tekturna HCT | New Drug Initial Review | Direct Renin Inhibitor | Novartis |
| Letairis | New Drug Appeal | Pulmonary Arterial Hypertension | Gilead |
| Megace ES | New Drug Appeal | Progestin | Par |
| Bystolic | New Drug Appeal | Beta-Blocker | Forest |
| Pristiq | New Drug Appeal | SNRI Antidepressant | Wyeth |
| Keppra XR | New Drug Appeal | Anticonvulsant | UCB |
| Exforge | New Drug Appeal | Antihypertensive Combination | Novartis |
| Tekturna | New Drug Appeal | Direct Renin Inhibitor | Novartis |